These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11070569)

  • 1. The role of statins in acute coronary syndromes: managing the unmet need.
    Jackson G
    Int J Clin Pract; 2000 Sep; 54(7):445-9. PubMed ID: 11070569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early statin therapy in acute coronary syndromes.
    Kinlay S; Ganz P
    Semin Vasc Med; 2003 Nov; 3(4):419-24. PubMed ID: 15199449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug insight: Statin use in the elderly.
    Raffel OC; White HD
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):318-28. PubMed ID: 16729010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use over time of statins in coronary patients in an Italian tertiary referral center.
    Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA
    Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute coronary syndromes without ST-segment elevation. From randomized clinical trials, to consensus guidelines, to clinical practice in Italy: need to close the circle].
    Savonitto S; Klugmann S
    Ital Heart J Suppl; 2004 Mar; 5(3):167-76. PubMed ID: 15116860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early statin therapy in acute coronary syndromes.
    Kinlay S
    Minerva Cardioangiol; 2003 Oct; 51(5):577-84. PubMed ID: 14551525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unstable angina--a definitive role for statins in secondary prevention.
    Colquhoun D
    Int J Clin Pract; 2000; 54(6):383-9. PubMed ID: 11092112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care.
    Kedward J; Dakin L
    Br J Gen Pract; 2003 Sep; 53(494):684-9. PubMed ID: 15103875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid lowering agents. How important are they in secondary prevention of coronary heart disease?
    Colquhoun DM
    Aust Fam Physician; 2002 Jan; 31(1):25-6, 29-30. PubMed ID: 11840884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statin use in patients with acute coronary syndromes and a serum low-density lipoproteinTsai TT; Nallamothu BK; Mukherjee D; Rubenfire M; Fang J; Chan P; Kline-Rogers E; Patel A; Armstrong DF; Eagle KA; Goldberg AD
    Am J Cardiol; 2005 Dec; 96(11):1491-3. PubMed ID: 16310427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X; Gross CR; Schommer J; Cline R; St Peter WL
    Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adherence to cardioprotective medications in coronary heart disease].
    Scardi S; Mazzone C; Di Lenarda A
    G Ital Cardiol (Rome); 2009 Apr; 10(4):241-8. PubMed ID: 19475879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?
    van Hout BA; Simoons ML
    Eur Heart J; 2001 May; 22(9):751-61. PubMed ID: 11350107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current questions regarding the use of statins in patients with coronary heart disease.
    Rallidis LS; Lekakis J; Kremastinos DT
    Int J Cardiol; 2007 Nov; 122(3):188-94. PubMed ID: 17399827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Broader indication for treatment with statins; the 'heart protection study'].
    Stalenhoef AF; Stuyt PM
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1921-3. PubMed ID: 12404905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early initiation of statin therapy in acute coronary syndromes: a review of the evidence.
    Rondina MT; Muhlestein JB
    J Interv Cardiol; 2005 Feb; 18(1):55-63. PubMed ID: 15788056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.